2 ms·
Regulating drug pricing is what has started to happen. And I’ll bet they don’t like that. A single payer system would at least change the negotiating power tha
by lostlogin 3y ago
Regulating drug pricing is what has started to happen. And I’ll bet they don’t like that.
A single payer system would at least change the negotiating power that big pharma has - even in a small market, drug companies hate dealing with a single buying. Here in New Zealand the point even made it into the TPP agreement negotiations. The US wanting our (deeply imperfect) healthcare system to be a bit more like the US one is rather grim.
- Scandiravian 3y agoCompletely agree. That's part of why Ozempic is cheaper in Europe. I actually worked for the company who negotiates drug purchases for all hospitals here in Denmark (Amgros), so I'm somewhat familiar with the process There's flaws in this approach as well, but in the end it's definitely an improvement to the issues US patients are facing in regards to costs